InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2026-03-24 | Laura Friedman(D-CA30) | house | Sale | $1,001 - $15,000 |
| 2026-03-19 | Richard Dean Dr McCormick(R-GA06) | house | Purchase | $1,001 - $15,000 |
| 2026-02-10 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
| 2026-01-29 | Thomas H. Kean(R-NJ07) | house | Purchase | $1,001 - $15,000 |
| 2025-12-19 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Sales | $44.33B+5.7% | $41.95B+4.6% | $40.11B-8.1% | $43.65B+1.3% | $43.08B |
| Cost of products sold, excluding amortization of intangible assets | $19.32B+3.3% | $18.71B+4.1% | $17.98B-6.1% | $19.14B+3.3% | $18.54B |
| Amortization of intangible assets | $1.68B-10.4% | $1.88B-4.5% | $1.97B-2.3% | $2.01B-1.7% | $2.05B |
| Research and development | $2.94B+3.4% | $2.84B+3.8% | $2.74B-5.1% | $2.89B+5.3% | $2.74B |
| Selling, general and administrative | $12.33B+5.4% | $11.70B+6.8% | $10.95B-2.7% | $11.25B-0.7% | $11.32B |
| Total Operating Cost and Expenses | $36.27B+3.3% | $35.13B+4.4% | $33.63B-4.7% | $35.29B+1.8% | $34.65B |
| Operating Earnings | $8.05B+18.0% | $6.83B+5.4% | $6.48B-22.5% | $8.36B-0.7% | $8.43B |
| Interest expense | $493.0M-11.8% | $559.0M-12.2% | $637.0M+14.2% | $558.0M+4.7% | $533.0M |
| Interest income | -$308.0M+10.5% | -$344.0M+10.6% | -$385.0M-110.4% | -$183.0M-325.6% | -$43.0M |
| Net foreign exchange (gain) loss | -$50.0M-85.2% | -$27.0M-165.9% | $41.0M+1950.0% | $2.0M+100.0% | $1.0M |
| Other (income) expense, net | -$548.0M-45.7% | -$376.0M+21.5% | -$479.0M-49.2% | -$321.0M-15.9% | -$277.0M |
| Earnings before Taxes | $8.47B+20.7% | $7.01B+5.2% | $6.66B-19.8% | $8.31B+1.2% | $8.21B |
| Taxes on Earnings | $1.94B+130.4% | -$6.39B-779.0% | $941.0M-31.5% | $1.37B+20.4% | $1.14B |
| Net Earnings | $6.52B-51.3% | $13.40B+134.2% | $5.72B-17.5% | $6.93B-2.0% | $7.07B |
| Basic Earnings Per Common Share (in dollars per share) | $3.7M-51.4% | $7.7M+133.8% | $3.3M | — | — |
| Diluted Earnings Per Common Share (in dollars per share) | $3.7M-51.3% | $7.6M+134.4% | $3.3M | — | — |
| Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) | $1.74B+0.1% | $1.74B+0.0% | $1.74B-0.7% | $1.75B-1.2% | $1.77B |
| Dilutive Common Stock Options (in shares) | $7.0M-12.5% | $8.0M-11.1% | $9.0M-18.2% | $11.0M-21.4% | $14.0M |
| Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) | $1.75B+0.0% | $1.75B-0.1% | $1.75B-0.9% | $1.76B-1.4% | $1.79B |
| Outstanding Common Stock Options Having No Dilutive Effect (in shares) | $1.0M-85.7% | $7.0M+40.0% | $5.0M+66.7% | $3.0M | $0 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Polen Global Growth adds META, ASML; exits ABT, ADBE among Q1 moves
How Investors Are Reacting To Abbott (ABT) Gaining FDA, CE Clearance For AI-Guided Ultreon 3.0
FDA says largest ever baby formula probe found U.S. supplies are safe
Jim Cramer Believes “BillionToOne’s a Winner”